Download PDF
Semin Thromb Hemost 2002; 28(2): 133-138
DOI: 10.1055/s-2002-27815
Copyright © 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

The Role of von Willebrand Factor in Platelet Function

Philip G. de Groot
  • University Medical Center, Utrecht, The Netherlands
Further Information

Publication History

Publication Date:
03 May 2002 (online)

    Permissions and Reprints

ABSTRACT

von Willebrand factor (vWF) has essential functions in the very first stage of hemostasis. At the site of vascular damage vWF binds immediately to exposed collagens, thereby facilitating the adhesion of platelets. After a first layer of platelets has been formed, vWF is also crucial as a link between platelets in the forming thrombus. In this article, the current knowledge on the role of vWF in primary hemostasis is reviewed.

KEYWORDS

von Willebrand factor - platelets - platelet adhesion - glycoprotein receptors - von Willebrand disease

REFERENCES

  • 1 Jaffe E A, Hoyer L W, Nachman R L. Synthesis of von Willebrand factor by cultured human endothelial cells.  Proc Natl Acad Sci USA . 1974;  71 1906-1909
    PubMedGoogle Scholar
  • 2 Nachman R, Levine R, Jaffe E A. Synthesis of factor VIII antigen by cultured guinea pig megakaryocytes.  J Clin Invest . 1977;  60 914-921
    PubMedGoogle Scholar
  • 3 Sadler J E. Biochemistry and genetics of von Willebrand factor.  Annu Rev Biochem . 1998;  67 395-424
    CrossrefPubMedGoogle Scholar
  • 4 Ruggeri Z M. Structure and function of von Willebrand factor.  Thromb Haemost . 1999;  82 576-584
    PubMedGoogle Scholar
  • 5 Rohdeghiero F, Castaman G, Ruggeri Z M, Tosetto A. The bleeding time in normal subjects is mainly determined by platelet von Willebrand factor and is independent from blood group.  Thromb Res . 1992;  65 605-615
    CrossrefPubMedGoogle Scholar
  • 6 Sarode R, Goldstein J, Sussman I I, Nagel R L, Tsai H M. Role of A and B blood group antigens in the expression of adhesive activity of von Willebrand factor.  Br J Haematol . 2000;  109 857-864
    CrossrefPubMedGoogle Scholar
  • 7 Ewenstein B M. Von Willebrand's disease.  Annu Rev Med . 1997;  48 525-545
    CrossrefPubMedGoogle Scholar
  • 8 Verweij C L, Diergaarde P J, Hart M, Pannekoek H. Full-length von Willebrand factor cDNA encodes a highly repetitive protein considerably larger than the mature vWF subunit.  EMBO J . 1986;  5 1839-1847
    PubMedGoogle Scholar
  • 9 Siedlecki C A, Lestini B J, Kottke-Marchant K. Shear dependent changes in the three dimensional structure of von Willebrand factor.  Blood . 1996;  88 2939-2950
    PubMedGoogle Scholar
  • 10 Sakariassen K S, Bolhuis P A, Sixma J J. Human blood platelets adhesion to artery subendothelium is mediated by factor VIII-von Willebrand factor bound to the subendothelium.  Nature . 1979;  279 636-638
    CrossrefPubMedGoogle Scholar
  • 11 Celikel R, Ruggeri Z M, Varughese K I. Von Willebrand conformation and adhesive function is modulated by an internalized water molecule.  Nature . 2000;  7 881-884
    PubMedGoogle Scholar
  • 12 Read M S, Potter J Y, Brinkhous K M. Venom coagglutinin for detection of von Willebrand factor activity in animal plasmas.  J Lab Clin Med . 1983;  101 74-82
    PubMedGoogle Scholar
  • 13 Ruggeri Z M, Zimmerman T S. von Willebrand factor and von Willebrand disease.  Blood . 1987;  70 895-904
    PubMedGoogle Scholar
  • 14 Sadler J E, Matsushita T, Dong Z, Tuley E A, Westfield L A. Molecular mechanism and classification of von Willebrand disease.  Thromb Haemost . 1995;  74 161-166
    PubMedGoogle Scholar
  • 15 Lankhof H, van Hoeij M, Schiphorst M E. A3 domain is essential for interaction of von Willebrand factor with collagen type III.  Thromb Haemost . 1996;  75 950-958
    PubMedGoogle Scholar
  • 16 Clemetson K J, Clemetson J M. Platelet GPIb-V-IX complex.  Structure, function, physiology and pathology. Semin Thromb Hemost . 1995;  21 130-136
    PubMedGoogle Scholar
  • 17 Savage B, Saldivar E, Ruggeri Z M. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor.  Cell . 1996;  84 289-297
    CrossrefPubMedGoogle Scholar
  • 18 Miura S, Li C Q, Cao Z. Interaction of von Willebrand factor domain A1 with platelet glycoprotein Ib alpha-(1-289). Slow intrinsic binding kinetics mediate rapid platelet adhesion.  J Biol Chem . 2000;  275 7539-7546
    CrossrefPubMedGoogle Scholar
  • 19 Nieuwenhuis H K, Sakariassen K S, Houdijk W PM, Nievelstein P E M F, Sixma J J. Deficiency of platelet membrane glycoprotein Ia is associated with a decreased platelet adhesion to subendothelium. A defect in platelet spreading.  Blood . 1986;  68 692-695
    PubMedGoogle Scholar
  • 20 Arai M, Yamamoto N, Moroi M. Platelets with 10% of the normal amount of glycoprotein VI have an impaired response to collagen that results in a mild bleeding tendency.  Br J Haematol . 1995;  89 124-130
    PubMedGoogle Scholar
  • 21 Kehrel B, Clementson K J, Anders O. Glycoprotein VI is a major collagen receptor for platelet activation: it recognizes the platelet-activating quarternary structure of collagen, whereas CD36, glycoprotein IIb/IIIa and von Willebrand factor do not.  Blood . 1998;  91 491-496
    PubMedGoogle Scholar
  • 22 Beumer S, IJsseldijk M JW, de Groot G Ph, Sixma J J. Platelet adhesion to fibronectin in flow: dependence on surface concentration and shear rate, role of platelet membrane glycoproteins GPIIb/IIIa and VLA5, and inhibition by heparin.  Blood . 1994;  84 3724-3733
    PubMedGoogle Scholar
  • 23 Weiss H J, Turitto V T, Baumgartner H R. Platelet adhesion and thrombus formation on subendothelium in platelets deficient in glycoproteins IIb-IIIa, Ib, and storage granules.  Blood . 1986;  67 322-330
    PubMedGoogle Scholar
  • 24 Weiss H J, Turitto V T, Baumgartner H R. Further evidence that glycoprotein IIb-IIIa mediates platelet spreading on subendothelium.  Thromb Haemost . 1991;  65 202-205
    PubMedGoogle Scholar
  • 25 Wu Y P, de Groot G Ph, Sixma J J. Shear stress-induced detachment of blood platelets adhered to various adhesive surfaces under flow.  Arterioscler Thromb Vasc Biol . 1997;  17 3202-3207
    PubMedGoogle Scholar
  • 26 Kulkarni S, Dopheide S M, Yap C L. A revised model of platelet aggregation.  J Clin Invest . 2000;  105 783-791
    CrossrefPubMedGoogle Scholar
  • 27 Ruggeri Z M. Old concepts and new developments in the study of platelet aggregation.  J Clin Invest . 2000;  105 699-701
    PubMedGoogle Scholar
  • 28 Ruggeri Z M, Dent J A, Saldivar E. Contribution of distinct adhesive interactions to platelet aggregation in flowing blood.  Blood . 1999;  94 172-178
    PubMedGoogle Scholar
  • 29 Wu Y P, Vink T, Schiphorst M. Platelet thrombus formation on collagen at high shear rates is mediated by von Willebrand factor-GPIb interaction and inhibited by vWF-GPIIb:IIIa interaction.  Arterioscler Thromb Vasc Biol . 2000;  20 1661-1667
    PubMedGoogle Scholar
  • 30 Tsuji S, Sugimoto M, Miyata S. Real time analysis of mural thrombus formation in various platelet aggregation disorders: distinct shear-dependent roles of platelet receptors and adhesive proteins under flow.  Blood . 1999;  94 968-975
    PubMedGoogle Scholar
  • 31 Weiss H J, Hawiger J, Ruggeri Z M. Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate.  J Clin Invest . 1989;  83 288-297
    CrossrefPubMedGoogle Scholar
  • 32 Berliner S, Niija K, Roberts J R, Houghten R A, Ruggeri Z M. Generation and characterization of peptide-specific antibodies that inhibit von Willebrand factor binding to glycoprotein IIb-IIIa without interaction with other adhesive molecules.  J Biol Chem . 1988;  263 7500-7505
    PubMedGoogle Scholar
  • 33 Matsushita T, Meyer D, Sadler J E. Localization of von Willebrand factor-binding sites for platelet glycoprotein Ib and botrocetin by charged-to-alanine scanning mutagenesis.  J Biol Chem . 2000;  275 11044-11049
    CrossrefPubMedGoogle Scholar
  • 34 Emsley J, Cruz M, Handin R, Liddington R. Crystal structure of the von Willebrand factor A1 domain and implications for the binding of platelet glycoprotein Ib.  J Biol Chem . 1998;  273 10396-10401
    CrossrefPubMedGoogle Scholar
  • 35 Huizinga E G, Martijn van der Plas R, Kroon J, Sixma J J, Gros P. Crystal structure of the A3 domain of human von Willebrand factor: implications for collagen binding.  Structure . 1997;  5 1147-1156
    CrossrefPubMedGoogle Scholar
  • 36 Bienkowska J, Cruz M, Atiemo A, Handin R, Liddington R. The von Willebrand factor A3 domain does not contain a metal ion-dependent adhesion site motif.  J Biol Chem . 1997;  272 25162-25167
    CrossrefPubMedGoogle Scholar
  • 37 Romein R AP, Bouma B, Wuyster W. Identification of the collagen binding site of the von Willebrand A3-domain.  J Biol Chem . 2001;  276 9985-9991
    CrossrefPubMedGoogle Scholar
  • 38 Sadler J E, Mannucci P M, Berntorp E. Impact, diagnosis and treatment of von Willebrand disease.  Thromb Haemost . 2000;  84 160-174
    Article in Thieme ConnectPubMedGoogle Scholar
  • 39 Stel H V, Sakariassen K S, de Groot G Ph, van Mourik A J, Sixma J J. The von Willebrand factor in the vessel wall mediates platelet adherence.  Blood . 1985;  65 85-90
    PubMedGoogle Scholar
  • 40 Fressinaud E, Baruch D, Rothschild C, Baumgartner H R, Meyer D. Platelet von Willebrand factor: evidence for its involvement in platelet adhesion to collagen.  Blood . 1987;  70 1214-1217
    PubMedGoogle Scholar
  • 41 d'Allesio P, Zwaginga J J, de Boer C H. Platelet adhesion to collagen in subtypes of type I von Willebrand's disease is dependent on platelet von Willebrand factor.  Thromb Haemost . 1990;  64 227-231
    PubMedGoogle Scholar
  • 42 de Groot G Ph, Federici A B, de Boer H C, et al. Von Willebrand factor synthesized by endothelial cells from a patient with type IIB von Willebrand disease supports platelet adhesion normally, but has an increased affinity for platelets.  Proc Natl Acad Sci USA . 1989;  86 3793-3797
    PubMedGoogle Scholar
  • 43 Nichols W C, Ginsburg D. von Willebrand disease.  Medicine . 1997;  76 1-20
    CrossrefPubMedGoogle Scholar
  • 44 Hillery C A, Mancuso D J, Sadler E J, et al. Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets.  Blood . 1998;  91 1572-1581
    PubMedGoogle Scholar
  • 45 Weiss H J, Meyer D, Rabinowitz R, et al. Pseudo-von Willebrand's disease. <~>An intrinsic platelet defect with aggregation by unmodified human factor VIII/Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.  N Engl J Med . 1982;  306 326-333
    CrossrefPubMedGoogle Scholar
  • 46 Russell S D, Roth G J. Pseudo-von Willebrand disease: a mutation in the platelet glycoprotein Ib alpha gene associated with a hyperactive surface receptor.  Blood . 1993;  81 1787-1791
    CrossrefPubMedGoogle Scholar
  • 47 Veyradier A, Jenkins S P, Fressinaud E, Meyer  D. Acquired von Willebrand syndrome: from pathophysiology to management.  Thromb Haemost . 2000;  84 175-182
    PubMedGoogle Scholar
  • 48 van Genderen J P, Vink T, Michiels J J. Acquired von Willebrand disease caused by an autoantibody selectively inhibiting the binding of von Willebrand factor to collagen.  Blood . 1994;  84 3378-3384
    PubMedGoogle Scholar
      >